ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.

Rachel B Salit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.